fda warning letter semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The Warning Letter Wake-Up Call

About Meet The Team About Us Reviews Our Approach Pricing Insurance Questions Membership Services All Services Medical Visits Treatments Specialty Lab Testing Conditions Thyroid Health Hormones Adrenal Health Metabolic Health Learn Blog Cases Recipes Research Resources Portal Telemed Patients Employees Shop NES Shop Amazon Shop Fullscript Gift Ideas Contact Book Now Advanced wellness, personalized care

Alluvi Healthcare offers personalized weight loss solutions and a compassionate approach, ensuring clients receive the support they need throughout their journey

Both concentrations keep every weekly dose within a single U-100 syringe (100 units / 1.0 mL)

To address these uncertainties, longer-term studies with larger and more globally diverse participant groups are necessary